Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › LA › NEW ORLEANS › PARISH HOSPITAL SERVICE DISTRICT FOR THE PARISH OF ORLEANS - DIST A

PARISH HOSPITAL SERVICE DISTRICT FOR THE PARISH OF ORLEANS - DIST A

NPI: 1225450588 · NEW ORLEANS, LA 70127 · General Acute Care Hospital · NPI assigned 01/06/2014

$49.84M
Total Medicaid Paid
688,730
Total Claims
576,891
Beneficiaries
225
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialGARNER, MARIO (CHIEF EXECUTIVE OFFICER)
NPI Enumeration Date01/06/2014

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 62,650 $4.45M
2019 76,035 $5.27M
2020 63,766 $3.72M
2021 123,436 $6.46M
2022 123,129 $7.98M
2023 138,269 $11.86M
2024 101,445 $10.10M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 58,133 52,223 $12.90M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 29,242 25,606 $8.95M
99283 Emergency department visit for the evaluation and management, moderate severity 36,863 33,298 $5.45M
64635 2,185 1,651 $2.01M
64493 2,064 1,592 $1.77M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 21,258 17,130 $1.77M
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 17,932 15,652 $1.31M
96361 Intravenous infusion, hydration; each additional hour 12,606 8,825 $1.28M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 32,624 28,451 $1.24M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 21,434 18,845 $1.09M
64636 2,243 1,595 $874K
64494 2,277 1,494 $772K
70450 Computed tomography, head or brain; without contrast material 2,512 2,231 $712K
62323 2,461 2,232 $707K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 17,711 14,484 $688K
96375 Therapeutic injection; each additional sequential IV push 11,166 8,996 $617K
74177 Computed tomography, abdomen and pelvis; with contrast material 602 517 $567K
71045 Radiologic examination, chest; single view 10,180 8,993 $493K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2,019 1,439 $458K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 11,334 9,790 $307K
80053 Comprehensive metabolic panel 37,748 32,260 $282K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 10,477 2,795 $274K
71046 Radiologic examination, chest; 2 views 3,585 3,200 $268K
81025 39,050 34,648 $244K
G0378 Hospital observation service, per hour 1,629 765 $229K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 42,591 36,216 $228K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 411 380 $218K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 1,383 1,004 $216K
62321 682 633 $201K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 831 350 $146K
45380 Colonoscopy, flexible; with biopsy, single or multiple 1,026 642 $143K
27096 89 80 $141K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,838 1,624 $132K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 4,553 4,243 $124K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk 386 317 $121K
36415 Collection of venous blood by venipuncture 55,103 44,511 $111K
73562 1,040 832 $108K
73560 1,039 845 $93K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2,748 2,396 $90K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 909 712 $88K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4,173 3,510 $88K
99282 Emergency department visit for the evaluation and management, low to moderate severity 868 825 $77K
C1776 Joint device (implantable) 33 28 $75K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,499 1,374 $74K
84484 8,281 6,910 $71K
64490 70 53 $70K
64483 44 42 $68K
73564 389 347 $64K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 756 662 $60K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 568 472 $57K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2,043 1,752 $56K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2,042 1,752 $56K
0001A 1,542 1,419 $52K
J0696 Injection, ceftriaxone sodium, per 250 mg 2,377 2,059 $49K
74176 Computed tomography, abdomen and pelvis; without contrast material 94 83 $46K
0002A 1,332 1,156 $45K
C9290 Injection, bupivacaine liposome, 1 mg 495 435 $43K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,436 1,322 $42K
80305 4,695 4,026 $41K
J7030 Infusion, normal saline solution , 1000 cc 4,028 3,407 $40K
20610 30 29 $40K
76705 Ultrasound, abdominal, real time with image documentation; limited 362 345 $39K
64491 82 51 $38K
J1885 Injection, ketorolac tromethamine, per 15 mg 6,519 5,775 $37K
87634 597 541 $37K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 4,205 3,834 $37K
81001 15,803 13,843 $37K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 4,841 4,174 $37K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 94 84 $35K
83880 1,559 1,383 $35K
83690 6,886 6,023 $35K
97161 658 583 $33K
0012A 1,060 951 $32K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1,393 412 $31K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 152 126 $29K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 297 194 $28K
94664 282 246 $28K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 3,387 1,545 $27K
0011A 999 955 $27K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,689 1,615 $24K
73130 263 219 $23K
81003 14,047 12,036 $22K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 44 41 $21K
J0780 Injection, prochlorperazine, up to 10 mg 1,394 1,220 $21K
87086 Culture, bacterial; quantitative colony count, urine 3,140 2,829 $21K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 455 372 $20K
94644 366 332 $20K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 805 757 $18K
80061 Lipid panel 1,652 1,540 $17K
J2704 Injection, propofol, 10 mg 6,640 4,899 $17K
0004A 486 431 $17K
73030 174 150 $17K
64633 15 12 $16K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 457 431 $15K
J0558 Injection, penicillin g benzathine and penicillin g procaine, 100,000 units 52 41 $15K
73221 13 12 $15K
99281 Emergency department visit for the evaluation and management, self-limited or minor 283 266 $14K
0071A 320 282 $13K
83036 Hemoglobin; glycosylated (A1C) 1,827 1,695 $13K
0013A 317 293 $12K
82550 2,774 2,407 $12K
80048 Basic metabolic panel (calcium, ionized) 2,109 1,727 $12K
87081 1,500 1,428 $10K
80047 1,140 982 $9K
73630 96 88 $9K
71275 Computed tomographic angiography, chest, with contrast material 12 12 $8K
73610 89 79 $7K
72170 67 63 $7K
64634 15 12 $7K
29827 18 12 $7K
84443 Thyroid stimulating hormone (TSH) 499 436 $6K
0031A 201 164 $6K
83735 1,416 1,176 $6K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 227 213 $6K
G0105 Colorectal cancer screening; colonoscopy on individual at high risk 19 15 $5K
80050 General health panel 155 145 $5K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 195 165 $5K
82150 903 799 $5K
0072A 118 103 $5K
J0690 Injection, cefazolin sodium, 500 mg 1,870 1,140 $5K
73502 42 41 $4K
72100 39 38 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,410 1,627 $4K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 197 179 $4K
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,817 2,416 $3K
85027 695 586 $3K
76819 Fetal biophysical profile; without non-stress testing 38 28 $3K
87430 262 241 $3K
82962 1,321 974 $3K
93350 12 12 $3K
82947 1,655 1,346 $3K
90674 182 156 $3K
93017 13 13 $2K
J2360 Injection, orphenadrine citrate, up to 60 mg 125 118 $2K
80076 270 241 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination 3,000 2,598 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 32 25 $2K
85610 566 509 $2K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 279 196 $2K
G0433 Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening 215 160 $2K
J2270 Injection, morphine sulfate, up to 10 mg 262 216 $2K
84100 493 436 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 262 212 $2K
J8540 Dexamethasone, oral, 0.25 mg 705 618 $2K
74022 12 12 $1K
J2003 Injection, lidocaine hydrochloride, 1 mg 369 288 $1K
74019 14 13 $1K
73110 14 12 $1K
83605 158 118 $1K
86706 117 108 $1K
80074 39 33 $1K
90715 25 24 $933.50
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 4,700 2,641 $930.69
87210 258 200 $915.84
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 46 40 $884.19
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) 714 557 $865.49
86803 70 66 $826.31
87070 96 85 $818.95
86756 53 52 $808.16
87088 114 109 $776.64
77067 Screening mammography, bilateral, including computer-aided detection 12 12 $748.70
85379 110 97 $741.65
86408 23 19 $716.21
J0500 Injection, dicyclomine hcl, up to 20 mg 23 12 $647.91
J2250 Injection, midazolam hydrochloride, per 1 mg 1,307 1,060 $601.26
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 553 373 $575.84
0064A 13 13 $553.14
J3370 Injection, vancomycin hcl, 500 mg 21 16 $549.31
86708 42 38 $475.24
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 30 27 $462.57
J3490 Unclassified drugs 170 82 $455.00
0054A 12 12 $454.58
83090 40 33 $430.08
86140 97 89 $414.40
96376 12 12 $394.47
84481 36 32 $384.64
85730 85 79 $381.05
86704 27 24 $334.07
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 12,871 10,492 $330.36
85651 85 77 $328.37
J2919 Injection, methylprednisolone sodium succinate, 5 mg 38 24 $325.77
86592 100 83 $324.54
J3010 Injection, fentanyl citrate, 0.1 mg 911 776 $310.28
85014 241 172 $308.53
87340 27 24 $298.65
J1200 Injection, diphenhydramine hcl, up to 50 mg 208 197 $248.11
G0475 Hiv antigen/antibody, combination assay, screening 29 24 $228.85
80320 32 12 $189.40
87077 26 24 $185.84
J2765 Injection, metoclopramide hcl, up to 10 mg 27 26 $167.53
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 78 72 $129.23
84439 15 14 $126.28
84702 12 12 $90.30
J0131 Injection, acetaminophen, not otherwise specified,10 mg 35 27 $84.23
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 14 12 $75.00
91300 3,447 2,834 $62.08
J0171 Injection, adrenalin, epinephrine, 0.1 mg 263 226 $59.06
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 48 39 $51.14
A6258 Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing 113 73 $45.94
85018 19 12 $37.92
A6223 Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing 362 309 $34.93
91301 2,601 2,107 $31.60
J1170 Injection, hydromorphone, up to 4 mg 104 71 $30.27
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 49 39 $29.29
85652 12 12 $27.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 15 15 $23.67
J2550 Injection, promethazine hcl, up to 50 mg 23 17 $19.45
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 14 13 $16.04
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 49 44 $14.68
88342 294 258 $9.73
A6222 Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing 305 266 $1.66
91305 41 39 $0.02
88304 14 13 $0.00
91307 445 365 $0.00
91303 234 181 $0.00
64450 55 24 $0.00
91306 13 13 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 12 12 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 22 12 $0.00
99001 2,071 1,413 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 116 61 $0.00
88312 88 77 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 26 15 $0.00
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 12 12 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 13 13 $0.00